Fig. 3 | npj Precision Oncology

Fig. 3

From: The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients

Fig. 3

Alteration in CEP counts during neoadjuvant chemotherapy with respect to regimen (A: FEC, B: TC, C: TP). The y-axis indicates CEP counts. In patients receiving the anthracycline-based regimen, the number of CEPs increased from pre-1st to pre-2nd cycle of chemotherapy (p = 0.016, Wilcoxon signed-rank test : two-sided)

Back to article page